MB, Levis & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Buy
12,243
+511
+4% +$70.6K 0.65% 29
2026
Q2
$1.51M Sell
11,732
-40
-0.3% -$4.68K 0.56% 33
2026
Q1
$1.42M Sell
11,772
-319
-3% -$36.8K 0.59% 32
2025
Q4
$1.27M Sell
12,091
-379
-3% -$35.6K 0.54% 32
2025
Q3
$1.05M Sell
12,470
-1,562
-11% -$129K 0.45% 32
2025
Q2
$1.11M Buy
14,032
+403
+3% +$32K 0.49% 34
2025
Q1
$1.22M Buy
13,629
+101
+0.7% +$9.43K 0.57% 32
2024
Q4
$1.35M Buy
13,528
+75
+0.6% +$7.73K 0.67% 27
2024
Q3
$1.53M Buy
13,453
+31
+0.2% +$3.68K 0.75% 23
2024
Q2
$1.66M Buy
13,422
+20
+0.1% +$2.58K 0.87% 22
2024
Q1
$1.77M Buy
13,402
+42
+0.3% +$5.18K 0.95% 22
2023
Q4
$1.46M Buy
13,360
+98
+0.7% +$10.2K 0.83% 22
2023
Q3
$1.37M Sell
13,262
-72
-0.5% -$7.76K 0.89% 22
2023
Q2
$1.54M Buy
13,334
+39
+0.3% +$4.43K 0.99% 21
2023
Q1
$1.41M Sell
13,295
-47
-0.4% -$5.07K 0.98% 22
2022
Q4
$1.48M Buy
+13,342
New +$1.36M 1.16% 21

Other funds holding MRK

MB, Levis & Associates's MRK Position: Q3 2026 in Review

MB, Levis & Associates increased its Merck (MRK) stake by 4.4% in Q3 2026, buying an estimated $70.6K and bringing the position to 12,243 shares worth $1.78M. The position accounts for 0.65% of the portfolio, ranked #29.

MB, Levis & Associates first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • MB, Levis & Associates held 12,243 shares of Merck worth $1.78M as of Q3 2026.
  • MB, Levis & Associates bought 511 Merck shares in Q3 2026, an estimated $70.6K.
  • Merck made up 0.65% of MB, Levis & Associates's portfolio in Q3 2026, its #29 holding.
  • MB, Levis & Associates first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.